We showed that while co-activation of MR and RA signalling resulted in both E2-dependent and E2-independent inhibition of cell proliferation, it exerts the opposite effect on the metabolic response of breast cancer cells, specifically promoting glycolysis and suppressing oxidative phosphorylation. The gene discussed is NR3C2; the disease is breast carcinoma.